Stockscreener 앱 받기
2.795
2.61%
-0.075
전일 마감가:
$2.87
열려 있는:
$2.79
하루 거래량:
41,799
Relative Volume:
0.19
시가총액:
$68.09M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-6.83%
1개월 성능:
+76.90%
6개월 성능:
-28.52%
1년 성능:
-75.27%
1일 변동 폭
$2.69
$2.92
1주일 범위
$2.69
$3.15
52주 변동 폭
$1.47
$17.31
Artiva Biotherapeutics Inc Stock (ARTV) Company Profile
명칭
Artiva Biotherapeutics Inc
전화
(858) 267-4467
주소
5505 MOREHOUSE DRIVE, SAN DIEGO
ARTV을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ARTV
Artiva Biotherapeutics Inc
|
2.795 | 75.04M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
376.31 | 96.11B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.08 | 60.40B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
428.16 | 54.91B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
668.50 | 41.30B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
295.70 | 33.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Artiva Biotherapeutics Inc Stock (ARTV) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-11 | 재개 | H.C. Wainwright | Buy |
| 2024-12-30 | 개시 | H.C. Wainwright | Buy |
| 2024-08-13 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-08-13 | 개시 | Jefferies | Buy |
| 2024-08-13 | 개시 | Needham | Buy |
| 2024-08-13 | 개시 | TD Cowen | Buy |
| 2024-08-13 | 개시 | Wedbush | Outperform |
모두보기
Artiva Biotherapeutics Inc 주식(ARTV)의 최신 뉴스
Positive Buy Rating for Artiva Biotherapeutics, Inc. Driven by Promising AlloNK Cell Therapy Developments - TipRanks
Buy Rating Affirmed for Artiva Biotherapeutics Amid Promising AlloNK Data and Strong Financial Position - TipRanks
Is it time to cut losses on Artiva Biotherapeutics Inc.Secure Asset Flow and Trend Pattern Analysis - Newser
Published on: 2025-08-06 19:40:30 - Newser
Artiva Biotherapeutics: Navigating Earnings Disappointment While Building a Foundation for Long-Term Growth - AInvest
Artiva Biotherapeutics Reports Second Quarter 2025 Financial Results, Recent Business Highlights - GlobeNewswire
Artiva Biotherapeutics (ARTV) to Release Earnings on Thursday - Defense World
How Artiva Biotherapeutics Inc. stock performs during market volatilityAI Trend Detection for Entry Timing - Newser
Will Artiva Biotherapeutics Inc. benefit from macro trendsPredictable Income Summary for Long-Term Trades - Newser
Multi factor analysis applied to Artiva Biotherapeutics Inc.Chart Driven Entry Timing for Swing Trades - Newser
Artiva Biotherapeutics Inc. Stock Support and Resistance Levels You Should KnowSummary of Long-Term Buy Zone Stocks - Newser
Pattern recognition hints at Artiva Biotherapeutics Inc. upsideShort-Term Profit Alert With Entry Forecast - Newser
Applying Elliott Wave Theory to Artiva Biotherapeutics Inc.Deep Learning Stock Forecast for Investors - Newser
Artiva Biotherapeutics Inc.’s Price Action Aligns with Quant SignalsDaily Market Summary Analysis Strategy - beatles.ru
Published on: 2025-08-04 22:00:03 - Newser
How volatile is Artiva Biotherapeutics Inc. stock compared to the marketConsistent triple-digit returns - Jammu Links News
What makes Artiva Biotherapeutics Inc. stock price move sharplyGet real-time alerts on top-performing stocks - Jammu Links News
Is Artiva Biotherapeutics Inc. a good long term investmentBreakthrough financial growth - Jammu Links News
Is Artiva Biotherapeutics Inc. stock overhyped or has real potentialFree Reliable Investment Entry Point Signals - Newser
How does Artiva Biotherapeutics Inc. generate profit in a changing economyAchieve exceptional returns with expert guidance - Jammu Links News
Is it the right time to buy Artiva Biotherapeutics Inc. stockUnlock real-time stock alerts for quick profits - Jammu Links News
How does Artiva Biotherapeutics Inc. compare to its industry peersBuild wealth faster with consistent investment plans - Jammu Links News
Is Artiva Biotherapeutics Inc. stock overvalued or undervaluedHigh-yield investments - Jammu Links News
What catalysts could drive Artiva Biotherapeutics Inc. stock higher in 2025Breakthrough stock performance - Jammu Links News
What are analysts’ price targets for Artiva Biotherapeutics Inc. in the next 12 monthsUnlock rapid growth potential in your portfolio - Jammu Links News
Should I hold or sell Artiva Biotherapeutics Inc. stock in 2025Unlock exclusive trading strategies for gains - Jammu Links News
What are Artiva Biotherapeutics Inc. company’s key revenue driversFree Capital Efficiency Planning - Jammu Links News
What drives Artiva Biotherapeutics Inc. stock priceOverwhelming financial success - Jammu Links News
Leading vs lagging indicators on Artiva Biotherapeutics Inc. performanceFree Technical Stock Breakout Predictions - Newser
Options Data Show Bullish Bias in Artiva Biotherapeutics Inc.Secure Capital Picks With Upside Potential Tracked - metal.it
Technical analysis overview for Artiva Biotherapeutics Inc. stockBuy Candidate Summary Based on Fundamentals - Newser
Is Artiva Biotherapeutics Inc. a growth stock or a value stockLow Risk Picks With Proven Results - jammulinksnews.com
Technical signs of recovery in Artiva Biotherapeutics IncFree Top Gaining Picks With Entry Signals - Newser
Is now a turning point for Artiva Biotherapeutics Inc.Asset Growth Pattern and Return Summary - Newser
Does Artiva Biotherapeutics Inc. qualify in momentum factor screeningYield Curve Outlook and Long-Term Implication Summary - Newser
Artiva Biotherapeutics Inc (ARTV) 재무 분석
Artiva Biotherapeutics Inc (ARTV)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.53%
0.00%
자본화:
|
볼륨(24시간):